AU4972096A - Peptides and compounds that bind to sh2 domains - Google Patents

Peptides and compounds that bind to sh2 domains

Info

Publication number
AU4972096A
AU4972096A AU49720/96A AU4972096A AU4972096A AU 4972096 A AU4972096 A AU 4972096A AU 49720/96 A AU49720/96 A AU 49720/96A AU 4972096 A AU4972096 A AU 4972096A AU 4972096 A AU4972096 A AU 4972096A
Authority
AU
Australia
Prior art keywords
domains
peptides
bind
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49720/96A
Inventor
Mikhail F. Gordeev
Eric Gordon
J. Russell Grove
Charles P Hart
Moon H Kim
Dinesh V. Patel
Anna Katrin Szardenings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymax Technologies NV
Original Assignee
Affymax Technologies NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymax Technologies NV filed Critical Affymax Technologies NV
Publication of AU4972096A publication Critical patent/AU4972096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
AU49720/96A 1995-02-01 1996-01-31 Peptides and compounds that bind to sh2 domains Abandoned AU4972096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38210095A 1995-02-01 1995-02-01
US382100 1995-02-01
PCT/US1996/001544 WO1996023813A1 (en) 1995-02-01 1996-01-31 Peptides and compounds that bind to sh2 domains

Publications (1)

Publication Number Publication Date
AU4972096A true AU4972096A (en) 1996-08-21

Family

ID=23507520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49720/96A Abandoned AU4972096A (en) 1995-02-01 1996-01-31 Peptides and compounds that bind to sh2 domains

Country Status (2)

Country Link
AU (1) AU4972096A (en)
WO (1) WO1996023813A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008934A2 (en) * 1995-06-19 1997-03-13 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
GB9517060D0 (en) * 1995-08-17 1995-10-25 Ciba Geigy Ag Acylated oligopeptide derivatives
GB9603227D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use
WO1997031016A2 (en) * 1996-02-23 1997-08-28 Ariad Pharmaceuticals, Inc. New inhibitors of sh2-mediated processes
DE69735208D1 (en) * 1996-07-16 2006-04-13 Georgetown University Washingt SUPPRESSION OF SIGNAL TRANSMISSION BY BINDING OF NON-PHOSPHORYLATED COMPOSITIONS
US5922697A (en) * 1996-10-02 1999-07-13 Warner-Lambert Company Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins
US6353023B1 (en) 1997-08-28 2002-03-05 Pharmacia & Upjohn Company Inhibitors of protein tyrosine phosphatase
US6410585B1 (en) * 1997-08-28 2002-06-25 Scott D. Larsen Inhibitors of protein tyrosine phosphatase
GB9722818D0 (en) * 1997-10-30 1997-12-24 Peptide Therapeutics Ltd A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
WO1999031066A1 (en) * 1997-12-18 1999-06-24 Boehringer Ingelheim Pharmaceuticals, Inc. Pyridones as src family sh2 domain inhibitors
US6156784A (en) * 1997-12-18 2000-12-05 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as phosphotyrosine mimics
US6307090B1 (en) 1999-01-22 2001-10-23 The United States Of America As Represented By The Department Of Health And Human Services Acylated oligopeptide derivatives having cell signal inhibiting activity
AU2736400A (en) * 1999-01-27 2000-08-18 University Of South Florida Inhibition of stat3 signal transduction for human cancer therapy
CA2368733C (en) 1999-03-23 2014-10-07 Terrence R. Burke, Jr. Phenylalanine derivatives
US7226991B1 (en) 1999-03-23 2007-06-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services Phenylalanine derivatives
AU6047600A (en) * 1999-06-02 2000-12-18 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain bindingto target protein, conjugates thereof, compositions and methods of synthesis an d use
US6951915B2 (en) 1999-06-02 2005-10-04 The United States Of America As Represented By The Department Of Health And Human Services Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
US7871981B2 (en) 1999-10-22 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility, angiogenesis, and metastasis
US7132392B1 (en) 1999-10-22 2006-11-07 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain
EP1383792A2 (en) 2000-08-22 2004-01-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Sh2 domain binding inhibitors
US7425537B2 (en) 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
US20050119163A1 (en) 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
CN103833593B (en) * 2014-03-21 2016-08-17 四川什邡市三高生化实业有限公司 A kind of preparation method of N-(the 9-fluorenylmethyloxycarbonyl)-O-tert-butyl group-TYR
CN107033033A (en) * 2016-10-14 2017-08-11 上海吉尔多肽有限公司 The synthetic method of hydroxytyrosine between a kind of N α fluorenylmethyloxycarbonyls
WO2019241308A1 (en) * 2018-06-11 2019-12-19 The Regents Of The University Of Colorado, A Body Corporate Effector protein identification by sh2 domain affinity chromatography coupled mass spectrometry

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5136093A (en) * 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof

Also Published As

Publication number Publication date
WO1996023813A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
AU4972096A (en) Peptides and compounds that bind to sh2 domains
AU5674696A (en) Compounds that bind to p185 and methods of using the same
AU1872595A (en) Peptides and compounds that bind to the il-1 receptor
AU1645895A (en) CTLA4 molecules and IL4-binding molecules and uses thereof
AU1116297A (en) Flk-1 binding protein
AU6046696A (en) Peptides and compounds that bind to a receptor
AU5117496A (en) Multimedia bridge
AU7524496A (en) Stable avidin composition and methods using same
AU7175694A (en) Lipopolysaccharide binding protein derivatives
AU7446194A (en) 4-arylamino-benzopyran and related compounds
AU2099795A (en) Cyano compounds and preparations thereof
AU4266596A (en) Composition and use
AU2872795A (en) Inhibition of platelet binding
AU7317496A (en) Activation of p53 protein
AU5716696A (en) Decorin binding protein compositions and methods of use
AU1117497A (en) Analgesic compounds and uses thereof
AU4413096A (en) Phenylalanine free proteins
AUPN178995A0 (en) Antigen composition
AU5452496A (en) Blends of organosilane compounds and their use
AU4394396A (en) Modified peptides
AU2018999A (en) Oligomers that bind to ku protein
AU2507895A (en) Protein guarantor composition and its application
AU6995594A (en) Aryltriflates and related compounds
AUPN177495A0 (en) Improved closure
AU2901495A (en) 5-lipoxygenase-activating protein ii